Cardurion Pharmaceuticals
78 employees
Biotech/Pharma
Series B · $560.0M
Open positions (2)
Company details
Team Size78
IndustryBiotech/Pharma
Funding
Total raised
$560.0M
Last stage
Series B
Investors
NEA
Total raised
$560.0M
Last stage
Series B
Investors
Michael E. Mendelsohn
Physician-scientist with world-class expertise in cardiovascular signaling pathways. Founded Cardurion in 2017.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.